Multiple Myeloma Drug Market in China 2021
- Ulat sa Market
- ID: HL10081C
- Oras ng Paghahatid: 1 Araw ng Negosyo
- Tag: Multiple Myeloma Drug
Paglalarawan
The multiple myeloma drug market in China in terms of revenue is set to grow by US$ 2 billion during 2021-2027, growing at a compound annual growth rate (CAGR) ng mga 18.8% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix.
Ang ulat ay nagbibigay ng napapanahong data ng laki ng merkado para sa panahon 2017-2020 at forecast na 2027 covering key market aspects like sales value for multiple myeloma drug. The China multiple myeloma drug market is segmented on the basis of region. By region, it is categorized into Central South China, East China, North China, Northeast China, Northwest China, and Southwest China.
The report has profiled some of the key players of the market such as I-MAB Biopharma Co. Ltd., Janssen Biotech Inc., Karyopharm Therapeutics Inc., Sanofi S.A., Takeda Pharmaceutical Co. Ltd.
Ang ulat ay isang napakahalagang mapagkukunan para sa mga kumpanya at organisasyon na aktibo sa industriyang ito. It provides a cohesive picture of the multiple myeloma drug market to help drive informed decision making for industry executives, mga gumagawa ng patakaran, akademiko, at mga analyst.
Saklaw ng Ulat
Rehiyon: Central South China, East China, North China, Northeast China, Northwest China, and Southwest China
Mga Taon na Itinuturing: Ang ulat na ito ay sumasaklaw sa panahon 2017 sa 2027
Mga Pangunahing Benepisyo para sa mga Stakeholder
Get a comprehensive picture of the China multiple myeloma drug market
Pinpoint ang mga sektor ng paglago at mga trend para sa pamumuhunan
Understand what the future of the multiple myeloma drug market in China looks like
Kilalanin ang mapagkumpitensya na landscape at window ng pagkakataon
Talaan ng mga Nilalaman
1. Kahulugan ng Market
2. Metodolohiya ng Pananaliksik
3. Market Data & Outlook
3.1 Halaga ng Market
3.2 Pagtataya ng Halaga sa Market
4. Multiple Myeloma Drug Market by Region
4.1 Central South China
4.2 East China
4.3 North China
4.4 Northeast China
4.5 Northwest China
4.6 Southwest China
5. Mga Profile ng Kumpanya
5.1 I-MAB Biopharma Co., Ltd.
5.2 Janssen Biotech, Inc.
5.3 Karyopharm Therapeutics Inc.
5.4 Sanofi S.A.
5.5 Takeda Pharmaceutical Co. Ltd.
6. Apendiks
6.1 Tungkol sa StrategyHelix
6.2 Pagtanggi
USD 450